RACLAU

Thank you very much for your response, Mark. Glad to hear that the TVEC+pembro combo worked for you.

Thanks so much for your helpful reply. It looks like TAVO + pembro may be more promising than T-VEC + pembro because of the  demonstrated benefit (in KEYNOTE-695) in patients with anti-PD-1 checkpoint resistance. I wonder if it would be worth looking into the possibility of expanded access for TAVO + pembro? Does anyone on the forum have experience with expanded access?